These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
869 related articles for article (PubMed ID: 21888945)
1. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α. Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945 [TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling. Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034 [TBL] [Abstract][Full Text] [Related]
3. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
4. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987 [TBL] [Abstract][Full Text] [Related]
5. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Mukai T; Otsuka F; Otani H; Yamashita M; Takasugi K; Inagaki K; Yamamura M; Makino H Biochem Biophys Res Commun; 2007 May; 356(4):1004-10. PubMed ID: 17397798 [TBL] [Abstract][Full Text] [Related]
6. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Gu K; Zhang L; Jin T; Rutherford RB Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233 [TBL] [Abstract][Full Text] [Related]
7. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells. Takeda M; Otsuka F; Otani H; Inagaki K; Miyoshi T; Suzuki J; Mimura Y; Ogura T; Makino H J Endocrinol; 2007 Jul; 194(1):87-99. PubMed ID: 17592024 [TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2. Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788 [TBL] [Abstract][Full Text] [Related]
9. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945 [TBL] [Abstract][Full Text] [Related]
10. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730 [TBL] [Abstract][Full Text] [Related]
12. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling. Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953 [TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells. Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611 [TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells. Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197 [TBL] [Abstract][Full Text] [Related]
16. Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling. Chung JE; Park JH; Yun JW; Kang YH; Park BW; Hwang SC; Cho YC; Sung IY; Woo DK; Byun JH Int J Med Sci; 2016; 13(11):806-818. PubMed ID: 27877072 [TBL] [Abstract][Full Text] [Related]
17. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779 [TBL] [Abstract][Full Text] [Related]
19. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. Korchynskyi O; Dechering KJ; Sijbers AM; Olijve W; ten Dijke P J Bone Miner Res; 2003 Jul; 18(7):1177-85. PubMed ID: 12854827 [TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycan chains of biglycan promote bone morphogenetic protein-4-induced osteoblast differentiation. Ye Y; Hu W; Guo F; Zhang W; Wang J; Chen A Int J Mol Med; 2012 Nov; 30(5):1075-80. PubMed ID: 22895561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]